CDH1 and neoplasm: We therefore believe that there existed a mechanism in the meningioma cell (even with the high degree of malignancy) which could inhibit the expression of E-cadherin and β-catenin, leading to the harmed cell-to-cell junctions, damaging of the tumor-brain interface and the blood-brain barrier.